Hepatocellular Carcinoma Monitored by F-18 Fluorodeoxyglucose Positron Emission Tomography After Laparoscopic Microwave Coagulation Therapy

A 46-year-old woman was hospitalized for treatment of hepatocellular carcinoma. On admission, positron emission tomography with F-18 fluorodeoxyglucose (FDG PET) showed a hot spot that coincided with the tumor; its standardized uptake value (SUV) was 5.47. Two weeks and 6 months after laparoscopic m...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 1999-07, Vol.24 (7), p.536-538
Main Authors: MORIKAWA, HIROYASU, SHIOMI, SUSUMU, SASAKI, NOBUMITSU, JOMURA, HISATO, SAKAGUCHI, HIROKI, NISHIGUCHI, SHUHEI, SEKI, SUICHI, KUROKI, TETSUO, KUBO, SHOJI, KAWABE, JOJI, OCHI, HIRONOBU
Format: Article
Language:English
Subjects:
Biological and medical sciences
Carcinoma, Hepatocellular - diagnostic imaging
Carcinoma, Hepatocellular - therapy
Female
Fluorodeoxyglucose F18
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - therapy
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Magnetic Resonance Imaging
Medical sciences
Microwaves - therapeutic use
Middle Aged
Tomography, Emission-Computed
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3851-1e2cdf8048cb1156cd36af0343ab4c08c3593515c679d3eb51ec38ad1c98d6fc3
cites
container_end_page 538
container_issue 7
container_start_page 536
container_title Clinical nuclear medicine
container_volume 24
creator MORIKAWA, HIROYASU
SHIOMI, SUSUMU
SASAKI, NOBUMITSU
JOMURA, HISATO
SAKAGUCHI, HIROKI
NISHIGUCHI, SHUHEI
SEKI, SUICHI
KUROKI, TETSUO
KUBO, SHOJI
KAWABE, JOJI
OCHI, HIRONOBU
description A 46-year-old woman was hospitalized for treatment of hepatocellular carcinoma. On admission, positron emission tomography with F-18 fluorodeoxyglucose (FDG PET) showed a hot spot that coincided with the tumor; its standardized uptake value (SUV) was 5.47. Two weeks and 6 months after laparoscopic microwave coagulation therapy, FDG PET showed a reduction in radioactive uptake to less than the background level, and the SUVs were 0.46 and 0.50, respectively. FDG PET performed 18 months after treatment showed a hot spot on the abdominal side of the site treated previously, and the SUV was 3.19. However, CT and MRI showed no evidence of recurrence. Our findings indicate that FDG PET is useful for evaluating the response to treatment and disease recurrence in patients with hepatocellular carcinoma.
doi_str_mv 10.1097/00003072-199907000-00021
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69880489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69880489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3851-1e2cdf8048cb1156cd36af0343ab4c08c3593515c679d3eb51ec38ad1c98d6fc3</originalsourceid><addsrcrecordid>eNp1ks1u1DAUhS0EokPhFZAXiF2KHSeOvaxGHVppKliUtXXjODMBJzfYSYc8Ay-NpzP8bLBk2Za-c-_VOSaEcnbFma4-sLQEq_KMa61ZlV5Z2jl_Rla8FDJjea6fkxUTUmS6kvkFeRXjV8a45LJ4SS44K1jOuFqRn7duhAmt8372EOgagu0G7IHe49BNGFxD64VuMq7oxs8YsHH4Y9n52WJ09DPGbgo40Ju-i7FLlwfscRdg3C_0up1coFsYIWC0OHaW3nc24AEeHV0j7FLH6Umzd0mxvCYvWvDRvTmfl-TL5uZhfZttP328W19vMytUyTPuctu0ihXK1pyX0jZCQstEIaAuLFNWlFqUvLSy0o1wdcldEkLDrVaNbK24JO9PdceA32cXJ5OGPzoAg8M5GqnVsbpOoDqBaegYg2vNGLoewmI4M8cgzO8gzJ8gzFMQSfr23GOue9f8Izw5n4B3ZwCiBd8GGGwX_3KqrHLNElacsAP65Gb85ueDC2bvwE97879_IH4BDPaivw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69880489</pqid></control><display><type>article</type><title>Hepatocellular Carcinoma Monitored by F-18 Fluorodeoxyglucose Positron Emission Tomography After Laparoscopic Microwave Coagulation Therapy</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>MORIKAWA, HIROYASU ; SHIOMI, SUSUMU ; SASAKI, NOBUMITSU ; JOMURA, HISATO ; SAKAGUCHI, HIROKI ; NISHIGUCHI, SHUHEI ; SEKI, SUICHI ; KUROKI, TETSUO ; KUBO, SHOJI ; KAWABE, JOJI ; OCHI, HIRONOBU</creator><creatorcontrib>MORIKAWA, HIROYASU ; SHIOMI, SUSUMU ; SASAKI, NOBUMITSU ; JOMURA, HISATO ; SAKAGUCHI, HIROKI ; NISHIGUCHI, SHUHEI ; SEKI, SUICHI ; KUROKI, TETSUO ; KUBO, SHOJI ; KAWABE, JOJI ; OCHI, HIRONOBU</creatorcontrib><description>A 46-year-old woman was hospitalized for treatment of hepatocellular carcinoma. On admission, positron emission tomography with F-18 fluorodeoxyglucose (FDG PET) showed a hot spot that coincided with the tumor; its standardized uptake value (SUV) was 5.47. Two weeks and 6 months after laparoscopic microwave coagulation therapy, FDG PET showed a reduction in radioactive uptake to less than the background level, and the SUVs were 0.46 and 0.50, respectively. FDG PET performed 18 months after treatment showed a hot spot on the abdominal side of the site treated previously, and the SUV was 3.19. However, CT and MRI showed no evidence of recurrence. Our findings indicate that FDG PET is useful for evaluating the response to treatment and disease recurrence in patients with hepatocellular carcinoma.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/00003072-199907000-00021</identifier><identifier>PMID: 10402018</identifier><identifier>CODEN: CNMEDK</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Biological and medical sciences ; Carcinoma, Hepatocellular - diagnostic imaging ; Carcinoma, Hepatocellular - therapy ; Female ; Fluorodeoxyglucose F18 ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - therapy ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Magnetic Resonance Imaging ; Medical sciences ; Microwaves - therapeutic use ; Middle Aged ; Tomography, Emission-Computed ; Tumors</subject><ispartof>Clinical nuclear medicine, 1999-07, Vol.24 (7), p.536-538</ispartof><rights>1999 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3851-1e2cdf8048cb1156cd36af0343ab4c08c3593515c679d3eb51ec38ad1c98d6fc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1857290$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10402018$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MORIKAWA, HIROYASU</creatorcontrib><creatorcontrib>SHIOMI, SUSUMU</creatorcontrib><creatorcontrib>SASAKI, NOBUMITSU</creatorcontrib><creatorcontrib>JOMURA, HISATO</creatorcontrib><creatorcontrib>SAKAGUCHI, HIROKI</creatorcontrib><creatorcontrib>NISHIGUCHI, SHUHEI</creatorcontrib><creatorcontrib>SEKI, SUICHI</creatorcontrib><creatorcontrib>KUROKI, TETSUO</creatorcontrib><creatorcontrib>KUBO, SHOJI</creatorcontrib><creatorcontrib>KAWABE, JOJI</creatorcontrib><creatorcontrib>OCHI, HIRONOBU</creatorcontrib><title>Hepatocellular Carcinoma Monitored by F-18 Fluorodeoxyglucose Positron Emission Tomography After Laparoscopic Microwave Coagulation Therapy</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>A 46-year-old woman was hospitalized for treatment of hepatocellular carcinoma. On admission, positron emission tomography with F-18 fluorodeoxyglucose (FDG PET) showed a hot spot that coincided with the tumor; its standardized uptake value (SUV) was 5.47. Two weeks and 6 months after laparoscopic microwave coagulation therapy, FDG PET showed a reduction in radioactive uptake to less than the background level, and the SUVs were 0.46 and 0.50, respectively. FDG PET performed 18 months after treatment showed a hot spot on the abdominal side of the site treated previously, and the SUV was 3.19. However, CT and MRI showed no evidence of recurrence. Our findings indicate that FDG PET is useful for evaluating the response to treatment and disease recurrence in patients with hepatocellular carcinoma.</description><subject>Biological and medical sciences</subject><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - therapy</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Magnetic Resonance Imaging</subject><subject>Medical sciences</subject><subject>Microwaves - therapeutic use</subject><subject>Middle Aged</subject><subject>Tomography, Emission-Computed</subject><subject>Tumors</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp1ks1u1DAUhS0EokPhFZAXiF2KHSeOvaxGHVppKliUtXXjODMBJzfYSYc8Ay-NpzP8bLBk2Za-c-_VOSaEcnbFma4-sLQEq_KMa61ZlV5Z2jl_Rla8FDJjea6fkxUTUmS6kvkFeRXjV8a45LJ4SS44K1jOuFqRn7duhAmt8372EOgagu0G7IHe49BNGFxD64VuMq7oxs8YsHH4Y9n52WJ09DPGbgo40Ju-i7FLlwfscRdg3C_0up1coFsYIWC0OHaW3nc24AEeHV0j7FLH6Umzd0mxvCYvWvDRvTmfl-TL5uZhfZttP328W19vMytUyTPuctu0ihXK1pyX0jZCQstEIaAuLFNWlFqUvLSy0o1wdcldEkLDrVaNbK24JO9PdceA32cXJ5OGPzoAg8M5GqnVsbpOoDqBaegYg2vNGLoewmI4M8cgzO8gzJ8gzFMQSfr23GOue9f8Izw5n4B3ZwCiBd8GGGwX_3KqrHLNElacsAP65Gb85ueDC2bvwE97879_IH4BDPaivw</recordid><startdate>199907</startdate><enddate>199907</enddate><creator>MORIKAWA, HIROYASU</creator><creator>SHIOMI, SUSUMU</creator><creator>SASAKI, NOBUMITSU</creator><creator>JOMURA, HISATO</creator><creator>SAKAGUCHI, HIROKI</creator><creator>NISHIGUCHI, SHUHEI</creator><creator>SEKI, SUICHI</creator><creator>KUROKI, TETSUO</creator><creator>KUBO, SHOJI</creator><creator>KAWABE, JOJI</creator><creator>OCHI, HIRONOBU</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199907</creationdate><title>Hepatocellular Carcinoma Monitored by F-18 Fluorodeoxyglucose Positron Emission Tomography After Laparoscopic Microwave Coagulation Therapy</title><author>MORIKAWA, HIROYASU ; SHIOMI, SUSUMU ; SASAKI, NOBUMITSU ; JOMURA, HISATO ; SAKAGUCHI, HIROKI ; NISHIGUCHI, SHUHEI ; SEKI, SUICHI ; KUROKI, TETSUO ; KUBO, SHOJI ; KAWABE, JOJI ; OCHI, HIRONOBU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3851-1e2cdf8048cb1156cd36af0343ab4c08c3593515c679d3eb51ec38ad1c98d6fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - therapy</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Magnetic Resonance Imaging</topic><topic>Medical sciences</topic><topic>Microwaves - therapeutic use</topic><topic>Middle Aged</topic><topic>Tomography, Emission-Computed</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MORIKAWA, HIROYASU</creatorcontrib><creatorcontrib>SHIOMI, SUSUMU</creatorcontrib><creatorcontrib>SASAKI, NOBUMITSU</creatorcontrib><creatorcontrib>JOMURA, HISATO</creatorcontrib><creatorcontrib>SAKAGUCHI, HIROKI</creatorcontrib><creatorcontrib>NISHIGUCHI, SHUHEI</creatorcontrib><creatorcontrib>SEKI, SUICHI</creatorcontrib><creatorcontrib>KUROKI, TETSUO</creatorcontrib><creatorcontrib>KUBO, SHOJI</creatorcontrib><creatorcontrib>KAWABE, JOJI</creatorcontrib><creatorcontrib>OCHI, HIRONOBU</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MORIKAWA, HIROYASU</au><au>SHIOMI, SUSUMU</au><au>SASAKI, NOBUMITSU</au><au>JOMURA, HISATO</au><au>SAKAGUCHI, HIROKI</au><au>NISHIGUCHI, SHUHEI</au><au>SEKI, SUICHI</au><au>KUROKI, TETSUO</au><au>KUBO, SHOJI</au><au>KAWABE, JOJI</au><au>OCHI, HIRONOBU</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatocellular Carcinoma Monitored by F-18 Fluorodeoxyglucose Positron Emission Tomography After Laparoscopic Microwave Coagulation Therapy</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>1999-07</date><risdate>1999</risdate><volume>24</volume><issue>7</issue><spage>536</spage><epage>538</epage><pages>536-538</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><coden>CNMEDK</coden><abstract>A 46-year-old woman was hospitalized for treatment of hepatocellular carcinoma. On admission, positron emission tomography with F-18 fluorodeoxyglucose (FDG PET) showed a hot spot that coincided with the tumor; its standardized uptake value (SUV) was 5.47. Two weeks and 6 months after laparoscopic microwave coagulation therapy, FDG PET showed a reduction in radioactive uptake to less than the background level, and the SUVs were 0.46 and 0.50, respectively. FDG PET performed 18 months after treatment showed a hot spot on the abdominal side of the site treated previously, and the SUV was 3.19. However, CT and MRI showed no evidence of recurrence. Our findings indicate that FDG PET is useful for evaluating the response to treatment and disease recurrence in patients with hepatocellular carcinoma.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>10402018</pmid><doi>10.1097/00003072-199907000-00021</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 1999-07, Vol.24 (7), p.536-538
issn 0363-9762
1536-0229
language eng
recordid cdi_proquest_miscellaneous_69880489
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Biological and medical sciences
Carcinoma, Hepatocellular - diagnostic imaging
Carcinoma, Hepatocellular - therapy
Female
Fluorodeoxyglucose F18
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - therapy
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Magnetic Resonance Imaging
Medical sciences
Microwaves - therapeutic use
Middle Aged
Tomography, Emission-Computed
Tumors
title Hepatocellular Carcinoma Monitored by F-18 Fluorodeoxyglucose Positron Emission Tomography After Laparoscopic Microwave Coagulation Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A39%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatocellular%20Carcinoma%20Monitored%20by%20F-18%20Fluorodeoxyglucose%20Positron%20Emission%20Tomography%20After%20Laparoscopic%20Microwave%20Coagulation%20Therapy&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=MORIKAWA,%20HIROYASU&rft.date=1999-07&rft.volume=24&rft.issue=7&rft.spage=536&rft.epage=538&rft.pages=536-538&rft.issn=0363-9762&rft.eissn=1536-0229&rft.coden=CNMEDK&rft_id=info:doi/10.1097/00003072-199907000-00021&rft_dat=%3Cproquest_cross%3E69880489%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3851-1e2cdf8048cb1156cd36af0343ab4c08c3593515c679d3eb51ec38ad1c98d6fc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69880489&rft_id=info:pmid/10402018&rfr_iscdi=true